Top Banner
Clinical Medical & Case Reports Open Journal of ISSN 2379-1039 Volume 3 (2017) Issue 1 Yadav S Open J Clin Med Case Rep: Volume 3 (2017) Pleomorphic lobular carcinoma of breast – cytological characteristics and differentials Kavita Munjal; Soma Yadav*; Deepak Agarwal *Soma Yadav Metropolis Healthcare Ltd. India Email: [email protected] Abstract Pleomorphic lobular carcinoma of breast (IPLC) is a very rare and distinct morphological variant of invasive lobular carcinoma (ILC), characterized by nuclear atypia and pleomorphism contrasted with the cytologic uniformity of ILC. Also it is associated with poor prognosis. Thus, cytological recognition of this tumour is important. We report a case with this unusual tumour in a ifty eight year old female that presented as a diagnostic dilemma on cytology. Introduction Pleomorphic lobular carcinoma(PLC) of breast is a distinct histological variant of invasive lobular carcinoma(ILC) [1,2,3,4,5]. Cytological recognition is important as the degree of pleomorphism exhibited in this speciic subtype may lead to misinterpretation of this particular subtype of lobular carcinoma as iniltrating ductal carcinoma. Also, it is associated with aggressive clinical course in having larger size, marked cytologic atypia, more prone to distant metastasis, higher chance of lymphovascular invasion and presentation at a higher stage [6,7,8,9,10]. The cytological literature on this entity is very little. We present a case of Pleomorphic Lobular Carcinoma diagnosed retrospectively, discuss the cytologic features that are useful in the recognition of this entity and the diagnostic pitfalls. Case Presentation A ifty eight year old female presented with a three month history of a self-discovered, progressively increasing, painless palpable lump in the left breast. She had no signiicant medical history. There was no family history of breast disease. On physical examination, a relatively ill-deined irm mass measuring 7x6 cm was palpable in the outer quadrant. The overlying skin appeared normal. There was evidence of palpable lymphadenopathy in the ipsilateral axilla. Mammography reported well-deined asymmetric density in the left breast (BIRADS-4). Fine Needle Aspiration Cytology (FNAC) was done and the smears showed scanty cellularity with occasional cells showing large nuclei. As the number of these large cells were very few and no conclusion could be drawn a repeat aspiration was performed which was highly cellular with large dyscohesive cells (Figure 1a). These cells were plasmacytoid, had coarse chromatin, inconspicuous to prominent nucleoli and variable amount of cytoplasm. Few binucleated cells were also noted. Mitotic igures were also seen (Figure 1b). The dissociated pleomorphic cell population Keywords aspiration cytology; breast carcinoma; pleomorphic lobular carcinoma
7

ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Feb 28, 2022

Download

Documents

dariahiddleston
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Clinical Medical & Case Reports

Open Journal of

ISSN2379-1039

Volume3(2017)Issue1

YadavS

OpenJClinMedCaseRep:Volume3(2017)

Pleomorphiclobularcarcinomaofbreast–cytologicalcharacteristicsanddifferentialsKavitaMunjal;SomaYadav*;DeepakAgarwal

*SomaYadav

MetropolisHealthcareLtd.India

Email:[email protected]

Abstract

Pleomorphic lobularcarcinomaofbreast(IPLC) isaveryrareanddistinctmorphologicalvariantof

invasivelobularcarcinoma(ILC),characterizedbynuclearatypiaandpleomorphismcontrastedwiththe

cytologicuniformityofILC.Alsoitisassociatedwithpoorprognosis.Thus,cytologicalrecognitionofthis

tumourisimportant.Wereportacasewiththisunusualtumourina�iftyeightyearoldfemalethat

presentedasadiagnosticdilemmaoncytology.

Introduction

Pleomorphiclobularcarcinoma(PLC)ofbreastisadistincthistologicalvariantofinvasivelobular

carcinoma(ILC)[1,2,3,4,5].Cytologicalrecognitionisimportantasthedegreeofpleomorphismexhibited

inthisspeci�icsubtypemayleadtomisinterpretationofthisparticularsubtypeoflobularcarcinomaas

in�iltratingductalcarcinoma.Also,itisassociatedwithaggressiveclinicalcourseinhavinglargersize,

markedcytologicatypia,morepronetodistantmetastasis,higherchanceoflymphovascularinvasionand

presentation at ahigher stage [6,7,8,9,10].The cytological literatureon this entity is very little.We

present a case of Pleomorphic Lobular Carcinoma diagnosed retrospectively, discuss the cytologic

featuresthatareusefulintherecognitionofthisentityandthediagnosticpitfalls.

CasePresentation

A �ifty eight year old female presented with a three month history of a self-discovered,

progressivelyincreasing,painlesspalpablelumpintheleftbreast.Shehadnosigni�icantmedicalhistory.

Therewasnofamilyhistoryofbreastdisease.Onphysicalexamination,arelativelyill-de�ined�irmmass

measuring7x6cmwaspalpableintheouterquadrant.Theoverlyingskinappearednormal.Therewas

evidenceofpalpablelymphadenopathyintheipsilateralaxilla.Mammographyreportedwell-de�ined

asymmetricdensityintheleftbreast(BIRADS-4).FineNeedleAspirationCytology(FNAC)wasdoneand

thesmearsshowedscantycellularitywithoccasionalcellsshowinglargenuclei.Asthenumberofthese

largecellswereveryfewandnoconclusioncouldbedrawnarepeataspirationwasperformedwhichwas

highly cellular with large dyscohesive cells (Figure 1a). These cells were plasmacytoid, had coarse

chromatin,inconspicuoustoprominentnucleoliandvariableamountofcytoplasm.Fewbinucleatedcells

werealsonoted.Mitotic�igureswerealsoseen(Figure1b).Thedissociatedpleomorphiccellpopulation

Keywordsaspirationcytology;breastcarcinoma;pleomorphiclobularcarcinoma

Page 2: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Page2

Vol3:Issue1:1208

OpenJClinMedCaseRep:Volume3(2017)

alongwithbinucleationandmitotic�iguresledtothediagnosisofmalignancy.Basedonthisreport,wide

excisionlumpectomywithguidedwirewasperformedasthepatientwasunwillingforaradicalexcision.

Thisspecimenshowedmultipledilatedvesselswithtumourembolishowingaggregatesofmalignant

cells (Figure 2a). These cells were similar to those seen in cytology smears showing large sized

plasmacytoidcellswithmoderatetoabundantcytoplasmandeccentricallyplacedlargeroundnuclei

(Figure2b).Manybinucleatedcellswerealsonoted.Adjacentstromashowedmultiplecalci�icspherules

andperiductallymphocyticin�iltrate.Adenosis,cysticallydilatedductsandfocalepithelialhyperplasia

was also noted. No primary foci of tumour were seen. Immunohistochemistry (IHC) workup was

performedon this specimen.Tumourcellswerepositive forPanCK(Figure3a),CK7andGCDFP-15

(Figure3b)andwerenegativeforE-cadherin(Figure3c),ERandPR.CD138andLCAwerealsonegative.

Thetumourcellsalsoshowed3+positivityforHer2-neu(Figure3d).AdiagnosisofPleomorphicLobular

carcinoma was given. The patient underwent Modi�ied Radical Mastectomy (MRM) with axillary

clearance,MRMspecimenwasreceivedwhichaftercarefulgrossingandsectioningshowedtwosmallfoci

of around 1cm eachwhich onmicroscopy showed tumour cells with similarmorphology as in the

lumpectomyspecimen.Nineoutoftwelvelymphnodesalsoshowedtumourmetastasis.

Discussion

The origin of PLC has been a matter of controversy because of the morphology and

immunophenotypic characteristics that overlap between ILC and invasive ductal carcinoma. The

histological architecture and pattern of tissue invasion closely resembles ILC; however the cellular

pleomorphismandnuclearatypiaaremoreconsistentwithIDC.Infact,someauthorshavesuggestedthat

PLCisahighgradeIDCthathaslostE-cadherinexpression.

Itpredominantlyaffectspostmenopausalwomenbetweentheagesof60-80years.[8,11,12]But

thoseassociatedwithBRCAmaypresentatayoungerage[13,14].Thismayexplainthedatathatwhich

saysthatPLCmayoccuroverawideagerange,varyingfrom35to80yearsofage[8].

ImportanceofdiagnosingPLCliesinthefactthatpatientwithPLCaremorelikelytodevelop

distantmetastasis and recurrence than thosewith classical forof ILC thusassociatedwithapoorer

outcome[6].However,itremainstobedetermined,whetherthepleomorphichistologyindependently

predictsaworseoutcomeorotherknownassociatednegativeprognosticfactorssuchaslargertumor

size, increased metastatic disease, and associated worse molecular subtypes commonly present in

pleomorphiccarcinomaaccountforthepoorprognosis[23,24].

Theclinicalandhistopathologicalfeaturesofthecasesofpleomorphiclobularcarcinomaofbreast

describedsofar,havebeensummarizedinTable1.

ThecytologyofPLCishybridbetweenlobularandductalcarcinoma[18,19,20,21].Thesmearsare

cellularwith individual cell being 2-3 times the size of cells in classical ILC,withmoderate nuclear

pleomorphism,prominentnucleoliandmoderatetoabundanteosinophilic,granularto�inelyvacuolated

cytoplasm.Multinucleatedmalignantcellsmaybeseenandmitosisisfrequent[10,15].Becauseofthe

degreeofpleomorphismandtendencytoformoccasionalaggregatesinsmallgroups,distinguishingit

fromhighgradeductalcarcinomacanbechallengingattimes[16].Ourcasedemonstratedplasmacytoid

cells due to eccentric nuclear location. Thedifferential for plasmacytoid cells in the breast cytology

Page 3: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Page3

Vol3:Issue1:1208

OpenJClinMedCaseRep:Volume3(2017)

includesILCanditspleomorphicvariant,IDCincludingitsapocrinetype,plasmacytoma,carcinomawith

endocrine differentiation and rarely granular cell tumours [17,18,19,20,21,22]. A higher nucleo-

cytoplasmicratio,absenceofcytoplasmicgranularityandnegativeGCDFP-15stainingaredistinguishing

featuresinfavourofIDC.Apocrinechangeissometimesfocallyseeninductalandlobularcarcinomabut

pureapocrinecarcinomasarerare(<1%).LikePLCtheyareGCDFPpositivebutareE-cadherinpositive

andmaybedistinguishedfromPLCbytheeosinophilicmacronucleoli,lackofintracytoplasmiclumina

and the solid/ comedogrowth pattern on histopathology. Plasmacytoma show a perinuclear hof,

cartwheelchromatinandlackofintracytoplasmicmucinthatmayhelptodifferentiatethemfromPLC.

Although,multinucleation,mitosisandpleomorphismmaybeseensimilartoPLC.Endocrinecarcinoma

ofbreastmayalsoshowplasmacytoidcells.Howeverthesecellsaresmaller,oflownucleargrade,have

thetypicalsaltandpepperchromatin,accentuationofstaininginparanuclearregionduetoaggregation

ofdensecoregranulesdetectedbyEMandpositivityforneuroendocrinemarkers.Theraregranularcell

tumoursofthebreastpossessgranularcytoplasmduetointarcytoplasmiclysosomes.Thetumourcells

areofschwanniandifferentiationandexpressS100.ThehistologyofPLCretainsthedistinctivegrowth

patternofILCbutshowsmarkedcellularatypia,nuclearpleomorhpismwithanincreasedmitoticrate

andmayshowsignetringcellsand/orshowapocrineorhistiocytoiddifferentiation.

Conclusion

Inconclusion,PLCmaybeachallengingdiagnosticdilemmaincytologyandrequireexperience

andregularexposuretobreastFNAC.Suboptimalyield,asinourcase,maybeacompoundingfactor.Its

behavioraldifferenceslikeincreasedrecurrence,multifocalityandbilateralitymarktheimportanceof

its recognition and differentiation from IDC as well as ILC. A thorough knowledge of the

cytohistomorphologicalfeaturesandahighdegreeofsuspicionisrequiredtodiagnosePLC.Incases

presentingasdilemma,histopathologyandimmunohistochemistrycomesinhandy.

Figures

Figure1a:On�ine-needleaspirationbiopsy,smearsarecellularwithpredominantlydyshesivemalignantcells.Tumor cells are plasmacytoid, eccentric nucleuswithprominent nucleoli and abundant cytoplasm. (MGG,x400)

Figure1b:Multinucleationandatypicalmitotic�igurenoted.(MGG,x400)

Page 4: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Page4

Vol3:Issue1:1208

OpenJClinMedCaseRep:Volume3(2017)

Figure 2a: Tumour emboli seen in multiple dilatedvessels.(H&E,x400)

Figure2b:Tumourcellsarelargesizedplasmacytoidwi th moderate to abundant cytop lasm andeccentricallyplacedlargeroundnuclei.(H&E,x100)

Figure 3a: PanCK: Immunostain shows positivecystoplasmicmembranestaining.(x400)

Figure 3b: GCDFP-15: Immunostain shows positivecytoplasmicstaining.(x100)

Figure 3c: E-cadherin: Immunostain for E-cadherinshowsabsenceofmembranousstaining.(x100)

Figure3d:Her2-neu:Immunostainshows3+positivestaining.(x400)

Page 5: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Page5

Vol3:Issue1:1208

OpenJClinMedCaseRep:Volume3(2017)

Table

References

1.RosenPP.Rosen'sbreastpathology.2nded.Philadelphia:LippincottWilliams&Wilkins;2001.

2.WeidnerN,Semple JP.Pleomorphicvariantof invasive lobular carcinomaof thebreast.HumPathol1992;

23:1167-71.

3. Eusebi V,Magalhaes F, Azzopardi JG. Pleomorphic lobular carcinoma of the breast: an aggressive tumour

showingapocrinedifferentiation.HumPathol1992;23:655-62.

4.MiddletonLP,PalaciosDM,BryantBR,KrebsP,OtisCN,MerinoMJ.Pleomorphiclobularcarcinoma:morphology,

immunochemistryandmolecularanalysis.AmJSurgPathol2000;24:1650-6.

5.DieciMV,OrvietoE,DominiciM,ConteP,GuarneriV.Rarebreastcancersubtypes:histological,molecular,and

clinicalpeculiarities.Oncologist.2014Aug;19(8):805-13.

6.BuchananCL,FlynnLW,MurrayMP,etal.Ispleomorphiclobularcarcinomareallyadistinctclinicalentity?JSurg

Oncol.2008;98(5):314–317.

7.EusebiV,MagalhaesF,AzzopardiJG.Pleomorphiclobularcarcinomaofthebreast:anaggressivetumorshowing

apocrinedifferentiation.HumPathol.1992;23(6):655–662.

Table1:Clinicalandhistopathologicalfeaturesofpleomorphiclobularcarcinomaofthebreastreportedsofar:

Age Sex Lateralization Size ER/PR/Her2neu

E-Cadherin Lymphnodestatus

Zahiretal(2013)

68 M Left 2.8x2.5cm +/+/+ - +

Ishidaetal(2013)

76 M Right 3x2.5cm +/-/- - -

Guptaetal(2012)

34 F Left 2x1.5cm -/-/- Notmentioned -

Manuchaetal(2011)

67 F Left Twofoci:1.1.7cm2.1.5cm

-/-/- - -

Rohinietal(2010)

55 M Left 3x2.5cm Notmentioned - -

Augustineetal(2007)(Threecases)

1.30

2.28

3.70

F

F

F

Left

Left

Left

4cm

10cm

Biopsyspecimen

Notmentioned

Notmentioned

Notmentioned

Notmentioned

Notmentioned

Notmentioned

+

+

Notassessed

Malyetal(2005)

44 M Left 2.5x2cm +/+/- - -

Presentcase

58 F Left 7x6cm -/-/+ - +

Page 6: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Page6

Vol3:Issue1:1208

OpenJClinMedCaseRep:Volume3(2017)

8.JacobsM,FanF,Taw�ikO.Clinicopathologicandbiomarkeranalysisofinvasivepleomorphiclobularcarcinoma

ascomparedwithinvasiveclassiclobularcarcinoma:anexperienceinourinstitutionandreviewoftheliterature.

AnnDiagnPathol.2012;16(3):185–189.

9. Weidner N, Semple JP. Pleomorphic variant of invasive lobular carcinoma of the breast. Hum Pathol.

1992;23(10):1167–1171.

10.GanganeN,Anshu,ShivkumarVB,SharmaS.Pleomorphiclobularcarcinomaofthebreast:acasereport.Acta

Cytol.2002;46(5):909–911.

11.MonhollenL,MorrisonC,AdemuyiwaFO,ChandrasekharR,KhouryT.Pleomorphic lobular carcinoma: a

distinctiveclinicalandmolecularbreastcancertype.Histopathology.2012;61(3):365–377.

12.RadhiJM.Immunohistochemicalanalysisofpleomorphiclobularcarcinoma:higherexpressionofp53and

chromograninandlowerexpressionofERandPgR.Histopathology.2000;36(2):156–160.

13.SimpsonPT,Reis-FilhoJS,LambrosMB,JonesC,SteeleD,MackayA,etal.Molecularpro�ilingpleomorphic

lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular

carcinomas.JPathol.2008;215(3):231–244.

14.MoeRE, AndersonBO.Distinctive biology of pleomorphic lobular carcinoma of the breast. J SurgOncol.

2005;90(2):47–50.

15.MonacoSE,DabbsDJ,Kanbour-ShakirA.Pleomorphiclobularcarcinomainpleural�luid:diagnosticpitfallfor

atypicalmesothelialcells.DiagnCytopathol.2008;36(9):657–661.

16.ButlerD,RosaM.Pleomorphiclobularcarcinomaofthebreast:amorphologicallyandclinicallydistinctvariant

oflobularcarcinoma.ArchPatholLabMed.2013Nov;137(11):1688-92.

17.JayaramG,SwainM,ChewMT,YipCH.Cytologicappearancesininvasivelobularcarcinomaofthebreast.Acta

Cytol2000;44:169-74.

18.JoshiA,KumarN,VermaK.Diagnosticchallengeoflobularcarcinomaonaspirationcytology.DiagnCytopathol

1998;18:179-83.

19.AbdullaM,HombalS,Al-JuwaiserA,NathM,StankovichD,KanbourA.Cytomorphologicfeaturesofclassicand

variantlobularcarcinoma:acomparativestudy.DiagnCytopathol2000;22:370-5.

20.AugerM,HuttnerI.Fineneedleaspirationcytologyofpleomorphiclobularcarcinomaofthebreast.Cancer

(CancerCytopathol)1997;81:29-32.

21.CangiarellaJ,WaismanJ,CohenJM,ChhiengD,SymmansWF,GoldenbergA.Plasmacytomaofthebreast.Acta

Cytol2000;44:91-4.

22.DeChiaraA,LositoS,TerraccianoL,DiGiacomoR,IaccarinoG,RubolottaMR.Primaryplasmacytomaofthe

breast.ArchPatholLabMed2001;125:1078-80.

23.Al-BaimaniK,BazzarelliA,ClemonsM,RobertsonSJ,AddisonC,etal.InvasivePleomorphicLobularCarcinoma

oftheBreast:Pathologic,Clinical,andTherapeuticConsiderations.ClinBreastCancer2015Dec;15(6):421-5.

24.NorendraS,JenkinsSM,KhoorA,NassarA(2015) Clinicaloutcomeinpleomorphiclobularcarcinoma:acase-

controlstudywithcomparisontoclassicinvasivelobularcarcinoma.AnnDiagnPathol.2015Apr;19(2):64-9.

Page 7: ISSN 2379-1039 Pleomorphic lobular carcinoma of breast ...

Page7

Vol3:Issue1:1208

OpenJClinMedCaseRep:Volume3(2017)

ManuscriptInformation:Received:November02,2016;Accepted:January09,2017;Published:January11,2017

1 1 3AuthorsInformation:KavitaMunjal ;SomaYadav *;DeepakAgarwal

1MetropolisHealthcareLtd.India2SriAurobindoInstituteofMedicalSciences,India

Citation: Munjal K, Yadav S, Agarwal D. Pleomorphic lobular carcinoma of breast – cytological characteristics and

differentials.OpenJClinMedCaseRep.2017;1208

Copy right statement: Content published in the journal follows Creative Commons Attribution License

(http://creativecommons.org/licenses/by/4.0). ©YadavS2017

Journal:Open JournalofClinical andMedicalCaseReports is an international, openaccess,peer reviewed Journal

focusingexclusivelyoncasereportscoveringallareasofclinical&medicalsciences.

Visitthejournalwebsiteatwww.jclinmedcasereports.com

Forreprints&otherinformation,contacteditorialof�[email protected]